Mohannad Kusti, MD, examines how comprehensive fertility benefits empower talent retention, yield a competitive edge, help prevent negative complications from improper fertility care, and mitigate costs from resulting absenteeism.
Can Lecanemab Succeed Where Aduhelm Failed?
September 28th 2022The announcement of positive phase 3 results for the investigational Alzheimer’s disease drug comes against a backdrop of Aduhelm flaming out. Both drugs are predicated on the theory that Alzheimer’s is caused by beta-amyloid deposits.
Read More